PRIMAXIN: IMIPENEM AND CILASTATIN FOR INJE.
IMIPENEM AND CILASTATIN FOR INJE. Key specifications include physical_form: POWDER, primary_container_type: VIAL, SINGLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 1000.000 MILLIGRAMS OF ACTIVE INGREDIENT, active_medicament_medicinal_strength: 500.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 500.000 MILLIGRAMS IMIPENEM EQUIVALENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-279-9627, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| primary_container_type | VIAL, SINGLE DOSE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 1000.000 MILLIGRAMS OF ACTIVE INGREDIENT |
| active_medicament_medicinal_strength | 500.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 500.000 MILLIGRAMS IMIPENEM EQUIVALENT |
| part_name_assigned_by_controlling_agency | IMIPENEM & CILASTATIN SOD F/INJ SGL DOSE FI 1000MG 25S |
| NSN | 6505-01-279-9627 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 MILLIGRAMS OF ACTIVE INGREDIENT |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | 15 ML CAPACITY GLASS VIAL SHALL HAVE A DOUBLE LEAD SCREW THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS: 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242; THE ASSEMBLY OF THE DRUG VIAL AND DILUENT CONTAINER SHALL PROVIDE A TAMPER-RESISTANT,STERILE,LEAK PROOF BARRIER; EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD; THE UPPER SHROUD SHALL BE A STERILITY BARRIER WITH A PULL RING TO ALLOW EASE OF OPENING; THE LOWER SHROUD SHALL PROVIDE AN INTEGRAL HANGER TO SUPPORT THE ASSEMBLY AND ADMINISTRATION SET; THE VIAL SHALL HAVE A VIEWING PORT TO ALLOW CONFIRMATION OF DRUG ADDITION AND DISSOLUTION |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | IMIPENEM & CILASTATIN SOD F/INJ SGL DOSE FI 1000MG 25S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 500.000 MILLIGRAMS IMIPENEM EQUIVALENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
No substitute or cross-reference records for this part.